2004 Saab 9-5 Arc Wagon 4-door 2.3l on 2040-cars

Auto blog

New owners still struggling to secure rights to use Saab name

Not to state the obvious, but if you're going to buy an automaker, it's probably advisable to secure rights to use the name.
That's what the new owners of Saab are trying to work out after buying the iconic Swedish automaker earlier this month, Automotive News reports.
National Electric Vehicle Sweden (NEVS), the Chinese-Japanese conglomerate, acquired the company's physical assets, including its factory in Trollhättan, but didn't get rights to use the Saab name and logo. Truckmaker Scania and defense company Saab AB maintain the name and logo rights, and will need to sign off on NEVS using it, according to the publication. The parties are in discussions.

Autoblog sell-it-yourself highlight: 2004 Saab 9-5 Aero Wagon

Want to sell your car? We make it safe, easy and free. Quickly create listings with up to 6 photos. Reach - literally - millions of buyers. Log in and create your free listings. In a recent Autoblog sampling of 10 pre-owned choices at least 10 years old and selling for under $10K, an Autoblog editor gave a shout-out to Saab's 9-5. And who could blame him? Despite its departure from the US market and subsequent closure as an automaker, Saab's brand still resonates among a committed core of enthusiasts. The Saab 9-5, available in both sedan and wagon variants, was the upper model of a two-model lineup; the 9-3 sedan sat below it, while the GM-sourced 9-7 SUV didn't appear until 2005. Both the sedan and wagon 9-5 were surprisingly roomy, and the Aero variant, pictured here, incredibly fast. This for-sale example, located in North Carolina, is at 176,000 miles a well-used example in need of (at least) a repaint. But this is the perfect color combination, plus a combo of sport and utility. Buy it for around $2K, hold another $5,000 in reserve to cover the obvious needs, and you can enjoy a distinctive piece of practical and powerful transportation. Related Video:

NEVS, the company that took over Saab, gets new majority owner

Chinese real estate conglomerate Evergrande Group, a key investor behind troubled electric vehicle startup Faraday Future, has acquired a 51 percent stake in NEVS. That's the Chinese-backed Swedish electric vehicle company that purchased the assets of Saab out of bankruptcy in 2012. The investment by subsidiary Evergrande Health Industry Group was valued at the equivalent of $930 million and is expected to help NEVS develop new EVs. Evergrande said it paid the first installment of $430 million on Jan. 15, with the remainder due by the end of the month. The remaining 49 percent stake is controlled by a holding company controlled by NEVS founder Kai Johan Jiang. "It means that NEVS will get a financial (sic) strong main owner who is very interested in developing our vision about green mobility transport solutions for the future," NEVS CEO Stefan Tilk said in a statement. NEVS, short for National Electric Vehicle Sweden, owns production facilities in Trollhattan, Sweden, and Tianjin, China, with another under construction in Shanghai. In late 2017 the company launched what apparently was limited production of the 9-3 EV, an electric vehicle based — you guessed it — on the old Saab 9-3 platform. The company now says it will be built in Tianjin starting later this year, with components coming from Trollhattan. It boasts a 186-mile range, in-car WiFi and a cabin air filter for the notoriously smoggy Chinese air. It also showed a battery-electric 9-3X concept at CES Asia in 2017, which is likely to be its next model pegged for production. The South China Morning Post, citing local media reports, says two of NEVS' models meet the standards for mass production in China. This content is hosted by a third party. To view it, please update your privacy preferences. Manage Settings. Definitely the best promotional video we've ever seen. Evergrande Health first came to Faraday Future's rescue back in 2017 with a promised $2 billion investment, but the two sides later went into arbitration in Hong Kong over a dispute about money following the first infusion of $800 million, leading the automaker to cut staff and wages last year, casting the future of FF into doubt. At the end of 2018, Faraday announced it had entered into a new restructuring agreement with an Evergrande Health subsidiary that sees them end litigation and jettison the previous investment agreement, taking Evergrande's investment in the company to 32 percent.